Rodos Biotarget GmbH
Records under this name other than patents Rodos Biotarget GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 2 of 2 · Back to Rodos Biotarget GmbH
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,059,475 | Targeted Nanocarriers for Targeted Drug Delivery of Gene Therapeutics Formerly held In force · High confidence | In force | High confidence | |
| US 10,357,457 | Targeted lipid-drug formulations for delivery of drugs to myeloid and lymphoid immune cells Term ended Term ended Sep 17, 2024 · USPTO record | Term ended | Term ended Sep 17, 2024 | USPTO record |